Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novartis H1N1 Vaccine in Pregnant Women
NCT00992719Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2009
- Primary completion
- Feb 2011
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Influenza A (H1N1) vaccine in influenza (3 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Number of Participants Reporting Maternal Complications of Pregnancy, Labor and Delivery, Number of Births With Neonatal Complications and 5 more. Started Nov 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00992719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992719.